Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Creighton Diabetes Center is a specialized clinical and research institution affiliated with Creighton University and CHI Health, located in Omaha, Nebraska. The center provides comprehensive, multidisciplinary care for patients with Type 1, Type 2, and gestational diabetes, utilizing advanced management tools such as continuous glucose monitoring and insulin pump therapy. In addition to its clinical services, the center is a hub for clinical research, participating in numerous multi-center trials to evaluate new pharmacological treatments and medical devices for metabolic disorders. It also offers American Diabetes Association-recognized education programs designed to empower patients through nutritional counseling and self-management training. As part of an academic medical center, it plays a critical role in the clinical training of endocrinology fellows and medical students.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Creighton Diabetes Center.